Biomet Offers $280M For Johnson & Johnson Trauma Biz
Medical device maker Biomet Inc. offered Tuesday to scoop up Johnson & Johnson's global trauma business for $280 million, a divestment that could help the health care giant assuage European Union...To view the full article, register now.
Already a subscriber? Click here to view full article